ATE253111T1 - Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung - Google Patents

Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung

Info

Publication number
ATE253111T1
ATE253111T1 AT98943332T AT98943332T ATE253111T1 AT E253111 T1 ATE253111 T1 AT E253111T1 AT 98943332 T AT98943332 T AT 98943332T AT 98943332 T AT98943332 T AT 98943332T AT E253111 T1 ATE253111 T1 AT E253111T1
Authority
AT
Austria
Prior art keywords
capsaicin receptor
receptor
polypeptides
capsaicin
related aspects
Prior art date
Application number
AT98943332T
Other languages
English (en)
Inventor
David J Julius
Michael Caterina
Anthony Brake
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE253111T1 publication Critical patent/ATE253111T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98943332T 1997-08-20 1998-08-20 Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung ATE253111T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91546197A 1997-08-20 1997-08-20
US7215198P 1998-01-22 1998-01-22
PCT/US1998/017466 WO1999009140A1 (en) 1997-08-20 1998-08-20 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
ATE253111T1 true ATE253111T1 (de) 2003-11-15

Family

ID=26753050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98943332T ATE253111T1 (de) 1997-08-20 1998-08-20 Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung

Country Status (8)

Country Link
US (3) US6335180B1 (de)
EP (1) EP1009804B1 (de)
JP (1) JP4444493B2 (de)
AT (1) ATE253111T1 (de)
AU (1) AU742391B2 (de)
CA (1) CA2298540A1 (de)
DE (1) DE69819345T2 (de)
WO (1) WO1999009140A1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444440B1 (en) 1997-03-07 2002-09-03 Human Genome Sciences, Inc. Vanilloid receptor-2
DE69819345T2 (de) 1997-08-20 2004-07-15 The Regents Of The University Of California, Oakland Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
WO1999037675A1 (en) * 1998-01-22 1999-07-29 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptors
EP1066381A1 (de) * 1998-01-27 2001-01-10 Smithkline Beecham Plc Homologe des menschlichen vanilloidrezeptors
EP0943683A1 (de) * 1998-03-10 1999-09-22 Smithkline Beecham Plc Menschliches Vanilloid Rezeptorhomolog Vanilrep1
EP0953638A1 (de) * 1998-03-11 1999-11-03 Synthelabo Dem menschlichen Vanilloid Rezeptor ähnlicher Kationenkanal
US6906178B2 (en) 1998-08-11 2005-06-14 Human Genome Sciences, Inc. Vanilloid receptor-2
US7063951B1 (en) 1998-11-13 2006-06-20 Millennium Pharmaceuticals, Inc. Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
EP1131433A1 (de) * 1998-11-13 2001-09-12 Millennium Pharmaceuticals, Inc. Mitglieder der capsaicin/vanilloid rezeptor familie und ihre anwendungen
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
GB9827016D0 (en) 1998-12-08 1999-02-03 Merck Sharp & Dohme Receptor protein
GB9907097D0 (en) * 1999-03-26 1999-05-19 Novartis Ag Organic compounds
JP2003520022A (ja) * 1999-04-15 2003-07-02 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ヒトのバニロイドレセプターvr1をコードするdna
US6421613B1 (en) * 1999-07-09 2002-07-16 Pioneer Hi-Bred International, Inc. Data processing of the maize prolifera genetic sequence
US6482611B1 (en) 1999-09-23 2002-11-19 Neurogen Corporation Human capsaicin receptor and uses thereof
US6455278B1 (en) * 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
HUP0300489A3 (en) * 2000-02-25 2006-06-28 Daiichi Seiyaku Co Novel protein and gene encoding the same
DE10043674A1 (de) * 2000-09-02 2002-03-21 Gruenenthal Gmbh Antisense Oligonukleotide
HUP0301805A3 (en) * 2000-09-02 2005-12-28 Gruenenthal Gmbh Antisense oligonucleotides against vanilloid receptor 1
JP2004511488A (ja) 2000-10-10 2004-04-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 新規標識レシニフェラトキシン誘導体
WO2002033411A1 (en) 2000-10-16 2002-04-25 Ortho-Mcneil Pharmaceutical, Inc. Improved ligand binding assays for vanilloid receptors
AU2002232456A1 (en) * 2000-12-01 2002-06-11 Bristol-Myers Squibb Company Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
US20030171275A1 (en) * 2000-12-20 2003-09-11 Baughn Mariah R. Transporters and ion channels
GB0128161D0 (en) * 2001-11-23 2002-01-16 Merck Sharp & Dohme Receptor protein
DK1472225T3 (da) 2002-02-01 2010-08-09 Euro Celtique Sa 2-Piperazinpyridiner, som er anvendelige til behandling af smerte
AU2002318168B2 (en) 2002-02-25 2007-12-13 Vaxiion Therapeutics, Llc Minicell compositions and methods
US6974818B2 (en) 2002-03-01 2005-12-13 Euro-Celtique S.A. 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
WO2003087158A2 (en) * 2002-04-16 2003-10-23 Bayer Healthcare Ag Regulation of human transient receptor potential channel
US7883846B2 (en) * 2002-05-31 2011-02-08 Sloan-Kettering Institute For Cancer Research Heterologous stimulus-gated ion channels and methods of using same
EP2270006A1 (de) 2002-08-08 2011-01-05 Amgen, Inc Pyridazin-Derivate zur Verwendung als Vanilloidrezeptorliganden
WO2004016167A1 (en) * 2002-08-16 2004-02-26 The General Hospital Corporation Non-invasive functional imaging of peripheral nervous system activation in humans and animals
US7582635B2 (en) * 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
EA008705B1 (ru) * 2003-04-08 2007-06-29 Алгоркс Фармасьютикалз, Инк. Получение и очистка синтетического капсаицина
MY142655A (en) * 2003-06-12 2010-12-15 Euro Celtique Sa Therapeutic agents useful for treating pain
US20050031717A1 (en) * 2003-07-09 2005-02-10 Desimone John A. Salt taste modification
EP2080757A1 (de) * 2003-07-24 2009-07-22 Euro-Celtique S.A. Zur Behandlung oder Vorbeugung von Schmerzen geeignete Heteroaryl-Tetrahydropiperidyl-Verbindungen
BRPI0412808A (pt) * 2003-07-24 2006-09-26 Euro Celtique Sa compostos de piperidina e composições farmacêuticas contendo os mesmos
PL1867644T3 (pl) 2003-07-24 2009-10-30 Euro Celtique Sa Związki heteroarylo-tetrahydropiperydylowe przydatne w leczeniu lub zapobieganiu bólu
SI1942106T1 (sl) 2003-08-01 2012-01-31 Euro Celtique Sa Terapevtska sredstva, uporabna za zdravljenje bolečine
PT2017276E (pt) 2003-09-22 2011-04-05 Euro Celtique Sa Compostos de fenilcarboxamida úteis para o tratamento da dor
DE602004017481D1 (de) * 2003-09-22 2008-12-11 Euro Celtique Sa Zur behandlung von schmerzen geeignete therapeutische mittel
CN1902178A (zh) * 2003-12-30 2007-01-24 欧洲凯尔特公司 用于治疗疼痛的哌嗪
US7751805B2 (en) * 2004-02-20 2010-07-06 Google Inc. Mobile image-based information retrieval system
US20070159522A1 (en) * 2004-02-20 2007-07-12 Harmut Neven Image-based contextual advertisement method and branded barcodes
US20050266435A1 (en) * 2004-03-09 2005-12-01 David Hackos VR1 receptors and uses thereof
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
CA2596194A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
CA2610644A1 (en) * 2005-05-31 2006-12-07 Devgen Nv Rnai for control of insects and arachnids
CA3068216C (en) 2006-06-22 2023-03-07 Board Of Regents Of The University Of Nebraska Magnetically coupleable robotic devices and related methods
US8679096B2 (en) 2007-06-21 2014-03-25 Board Of Regents Of The University Of Nebraska Multifunctional operational component for robotic devices
WO2008057300A2 (en) * 2006-10-27 2008-05-15 Redpoint Bio Corporation Trpvi antagonists and uses thereof
EP2479173A1 (de) 2007-04-27 2012-07-25 Purdue Pharma LP Zur Behandlung von Schmerzen geeignete therapeutische Mittel
EP2604599A1 (de) 2007-04-27 2013-06-19 Purdue Pharma LP TRPV1-Antagonisten und ihre Verwendung
EP3078344B1 (de) 2007-07-12 2020-02-26 Board of Regents of the University of Nebraska Betätigung in robotischen vorrichtungen
JP2010536435A (ja) 2007-08-15 2010-12-02 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ 医療用膨張、取り付けおよび送達装置、ならびに関連する方法
WO2009114143A1 (en) * 2008-03-12 2009-09-17 Brown University Treatment and prophylaxis of epilepsy and febrile seizures
US8703962B2 (en) * 2008-10-24 2014-04-22 Purdue Pharma L.P. Monocyclic compounds and their use as TRPV1 ligands
US8546388B2 (en) * 2008-10-24 2013-10-01 Purdue Pharma L.P. Heterocyclic TRPV1 receptor ligands
US8759362B2 (en) * 2008-10-24 2014-06-24 Purdue Pharma L.P. Bicycloheteroaryl compounds and their use as TRPV1 ligands
US8722964B2 (en) * 2009-04-23 2014-05-13 Transposagen Biopharmaceuticals, Inc. Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
EP2449112A1 (de) 2009-07-01 2012-05-09 Transposagen Biopharmaceuticals, Inc. Genetisch modifizierte rattenmodelle für schwere kombinierte immundefizienz (scid)
US20110145936A1 (en) * 2009-07-30 2011-06-16 Ostertag Eric M Genetically Modified Rat Models for Pharmacokinetics
WO2011017518A2 (en) * 2009-08-05 2011-02-10 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for drug metabolism
EP2467013A2 (de) * 2009-08-20 2012-06-27 Transposagen Biopharmaceuticals, Inc. Genetisch modifizierte rattenmodelle für schmerz
EP2717796B1 (de) 2011-06-10 2020-02-26 Board of Regents of the University of Nebraska In vivo gefässabdichtender endeffektor
US9273043B2 (en) 2011-06-22 2016-03-01 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
EP2732344B1 (de) 2011-07-11 2019-06-05 Board of Regents of the University of Nebraska Robotisches chirurgisches system
AU2012293417A1 (en) 2011-08-10 2013-05-02 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
EP3730031A1 (de) 2011-10-03 2020-10-28 Board of Regents of the University of Nebraska Robotische chirurgische vorrichtungen und systeme
WO2013106569A2 (en) 2012-01-10 2013-07-18 Board Of Regents Of The University Of Nebraska Methods, systems, and devices for surgical access and insertion
EP2844181B1 (de) 2012-05-01 2021-03-10 Board of Regents of the University of Nebraska Robotische einzelstandortvorrichtung sowie entsprechende systeme
US9010214B2 (en) 2012-06-22 2015-04-21 Board Of Regents Of The University Of Nebraska Local control robotic surgical devices and related methods
US12295680B2 (en) 2012-08-08 2025-05-13 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
US9770305B2 (en) 2012-08-08 2017-09-26 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
CA2880622C (en) 2012-08-08 2021-01-12 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
CA2906672C (en) 2013-03-14 2022-03-15 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to force control surgical systems
US9743987B2 (en) 2013-03-14 2017-08-29 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to robotic surgical devices, end effectors, and controllers
CA2906772C (en) 2013-03-15 2021-09-21 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
CA2918531A1 (en) 2013-07-17 2015-01-22 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
CA2941903A1 (en) 2014-04-01 2015-10-08 Koti Tatachar Sreekrishna Method for screening trp channels
EP3191009B1 (de) 2014-09-12 2021-03-31 Board of Regents of the University of Nebraska Schnelllösbare endeffektoren sowie entsprechende systeme
WO2016077478A1 (en) 2014-11-11 2016-05-19 Board Of Regents Of The University Of Nebraska Robotic device with compact joint design and related systems and methods
CN108472030B (zh) 2015-08-03 2021-06-18 内布拉斯加大学董事会 机器人手术装置系统及相关方法
US10751136B2 (en) 2016-05-18 2020-08-25 Virtual Incision Corporation Robotic surgical devices, systems and related methods
CN110248614B (zh) 2016-08-25 2023-04-18 内布拉斯加大学董事会 快速释放工具耦接器以及相关系统和方法
WO2018045036A1 (en) 2016-08-30 2018-03-08 Board Of Regents Of The University Of Nebraska Robotic device with compact joint design and an additional degree of freedom and related systems and methods
US11198972B2 (en) 2016-10-25 2021-12-14 The Procter & Gamble Company Fibrous structures
WO2018081191A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Differential pillow height fibrous structures
WO2018098319A1 (en) 2016-11-22 2018-05-31 Board Of Regents Of The University Of Nebraska Improved gross positioning device and related systems and methods
WO2018102430A1 (en) 2016-11-29 2018-06-07 Virtual Incision Corporation User controller with user presence detection and related systems and methods
WO2018112199A1 (en) 2016-12-14 2018-06-21 Virtual Incision Corporation Releasable attachment device for coupling to medical devices and related systems and methods
EP3687370B1 (de) 2017-09-27 2024-11-20 Virtual Incision Corporation Robotische chirurgische vorrichtungen mit verfolgungskameratechnologie und verwandte systeme
WO2019136360A1 (en) 2018-01-05 2019-07-11 Board Of Regents Of The University Of Nebraska Single-arm robotic device with compact joint design and related systems and methods
CN114302665B (zh) 2019-01-07 2025-12-19 虚拟切割有限公司 机器人辅助手术系统以及相关装置和方法
CN110045108B (zh) * 2019-05-28 2021-10-29 江南大学 一种基于辣椒碱指标的地沟油酶联免疫检测试剂盒及其检测方法
GB201918103D0 (en) * 2019-12-10 2020-01-22 Oblique Therapeutics Ab Epitopes and antibodies
JP2023532977A (ja) 2020-07-06 2023-08-01 バーチャル インシジョン コーポレイション 外科用ロボット位置決めシステム並びに関連する装置及び方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5074977A (en) 1987-05-05 1991-12-24 The Washington Technology Center Digital biosensors and method of using same
DE68926118T2 (de) 1988-08-18 1996-08-22 Australian Membrane And Biotechnology Research Institute Ltd. Commonwealth Scientific And Industrial Research Organization, North Ryde, Neusuedwales Verbesserungen an der empfindlichkeit und der selektivität von ionenkanalmembranbiosensoren
ATE153673T1 (de) 1989-01-27 1997-06-15 Au Membrane & Biotech Res Inst Rezeptormembranen und selektive steuerung des ionenflusses durch ionophoren
US5491097A (en) 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
US5328847A (en) 1990-02-20 1994-07-12 Case George D Thin membrane sensor with biochemical switch
US5232684A (en) * 1990-06-29 1993-08-03 The United States Of America As Represented By The Department Of Health And Human Services Labelled resiniferatoxin, compositions thereof, and methods for using the same
DE69819345T2 (de) 1997-08-20 2004-07-15 The Regents Of The University Of California, Oakland Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
EP1066381A1 (de) 1998-01-27 2001-01-10 Smithkline Beecham Plc Homologe des menschlichen vanilloidrezeptors
EP0943683A1 (de) * 1998-03-10 1999-09-22 Smithkline Beecham Plc Menschliches Vanilloid Rezeptorhomolog Vanilrep1
EP0953638A1 (de) 1998-03-11 1999-11-03 Synthelabo Dem menschlichen Vanilloid Rezeptor ähnlicher Kationenkanal
EP1131433A1 (de) 1998-11-13 2001-09-12 Millennium Pharmaceuticals, Inc. Mitglieder der capsaicin/vanilloid rezeptor familie und ihre anwendungen
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
JP2003520022A (ja) 1999-04-15 2003-07-02 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ヒトのバニロイドレセプターvr1をコードするdna
CA2359955A1 (en) 1999-11-12 2001-05-17 Abbott Laboratories Human vanilloid receptor gene
WO2001068857A2 (en) 2000-03-15 2001-09-20 Millennium Pharmaceuticals, Inc. 18615 and 48003, human ion channels and uses therefor
JP3501775B2 (ja) 2000-05-31 2004-03-02 ファイザー株式会社 ヒトバニロイド受容体様タンパク質

Also Published As

Publication number Publication date
US6335180B1 (en) 2002-01-01
US20030049728A1 (en) 2003-03-13
EP1009804A1 (de) 2000-06-21
DE69819345D1 (de) 2003-12-04
JP4444493B2 (ja) 2010-03-31
US6790629B2 (en) 2004-09-14
AU9115698A (en) 1999-03-08
JP2001514879A (ja) 2001-09-18
AU742391B2 (en) 2002-01-03
CA2298540A1 (en) 1999-02-25
WO1999009140A1 (en) 1999-02-25
DE69819345T2 (de) 2004-07-15
EP1009804A4 (de) 2001-05-16
US7097991B2 (en) 2006-08-29
EP1009804B1 (de) 2003-10-29
US20050095650A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
DE69819345D1 (de) Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
CA2309903A1 (en) Nucleic acid sequences encoding capsaicin receptor
ATE189607T1 (de) Dna codierend für einen menschlichen neuropeptid y/peptid yy/pankreaspolypeptid-rezeptor (y4) und seine verwendung
DE69636437D1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
CA2395724A1 (en) Nucleic acids, proteins, and antibodies
NZ236511A (en) Polypeptides containing sequences from residues 61 to 82 or 104 to 129 of human il-4 or subsequences thereof; antibodies and pharmaceutical compositions
HUP0104937A2 (hu) Új, G-fehérjéhez kapcsolt receptorfehérje, DNS-e és ligandja
ES2083344T1 (es) Dna que codifica un receptor 5-ht1f humano y utilizacion del mismo.
ATE362982T1 (de) ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
DE69834027D1 (de) Tumor-nekrose-faktor rezeptor 5
Barton et al. A tissue specific IL‐1 receptor antagonist homolog from the IL‐1 cluster lacks IL‐1, IL‐1ra, IL‐18 and IL‐18 antagonist activities
Hsu et al. Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers
Khattiya et al. Identification of a novel Japanese flounder (Paralichthys olivaceus) CC chemokine gene and an analysis of its function
ATE132162T1 (de) Humane gammainterferonantagonisten
ES2150495T3 (es) Ligandos de flt3 purificados de mamifero y agonistas y antagonistas de los mismos.
DE69417223D1 (de) Ein menschlicher t-zell rezeptor der protein g-gekoppelte rezeptor familie
DK0486572T3 (da) Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf
WO2004045369A3 (en) Nuclear receptor-based diagnostic, therapeutic, and screening methods
US20030017456A1 (en) Diagnosis and treatment and related preparations
Boivin et al. Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide
Crass et al. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand
Zoffmann et al. Synthesis and characterization of fluorescent and photoactivatable MIP-1α ligands and interactions with chemokine receptors CCR1 and CCR5
EP1403281A4 (de) Neuer ligand und dna davon
ATE247668T1 (de) Für den prostaglandinrezeptor kodierendes gen, damit transformierte zelle und dessen expressionsprodukt
KR970015600A (ko) Atp-민감성의 새로운 칼륨-통로 단백질과 그의 유전자

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties